A convergence of neurobiological and clinical evidence supports what many experienced clinicians have long suspected: combining psychotherapy with brain-directed neuromodulation may improve outcomes for patients whose symptoms have not fully responded to either approach alone (Bajbouj & Padberg, 2014). For patients on the Main Line and throughout the Delaware County and greater Philadelphia area, this evidence has direct practical implications — it means that TMS therapy or SPRAVATO® treatment paired with well-structured psychotherapy is a reasonable, evidence-grounded strategy for supporting sustained remission. At Complete Mind Care in Villanova, the integration of psychotherapy with neuromodulation is a foundational element of how we design individualized treatment plans for our patients.
The Neuroscientific Rationale for Integration
To understand why combining psychotherapy with neuromodulation works, it helps to understand what each approach does at the neural level. Neuromodulation techniques such as TMS and SPRAVATO® operate by modifying the brain’s baseline physiological state — TMS by directly stimulating or inhibiting cortical activity in targeted regions, SPRAVATO® by acting on glutamatergic signaling and downstream pathways involved in synaptic plasticity (Abdallah et al., 2018; Duman et al., 2019). Both approaches may create a neurobiological environment characterized by heightened plasticity — a window during which the brain may be more capable of learning and reorganizing than it is in its dysregulated depressed or anxious state.
Psychotherapy, by contrast, works through learning. Cognitive-behavioral therapy, acceptance-based approaches, and exposure-based techniques all rely on the brain’s ability to form new associations, revise maladaptive cognitive schemas, and consolidate new behavioral repertoires. These learning processes depend on exactly the kind of synaptic plasticity that neuromodulation is intended to support. When psychotherapy is delivered within the neuroplasticity window created by TMS or SPRAVATO®, the brain may be better positioned to encode and retain the changes the therapy aims to produce — a synergy grounded in the mechanisms of memory consolidation and cortical reorganization.
What the Clinical Evidence Shows
Clinical research has examined combined neuromodulation and psychotherapy across several treatment models. Isserles et al. (2011) found that cognitive-emotional reactivation during deep transcranial magnetic stimulation affected antidepressant outcomes in patients with depression. A large naturalistic study of rTMS combined with psychotherapy reported clinically meaningful response and remission outcomes, with many patients maintaining gains at follow-up (Donse et al., 2018). More recent reviews describe initial support for pairing noninvasive brain stimulation with psychotherapy or mindfulness-based approaches, while also noting that the field is still refining optimal timing, sequencing, and patient-selection protocols (Kochanowski et al., 2024).
For a deeper look at how TMS integrates into real-world mental health care, our post on integrating TMS into a holistic approach for wellbeing offers additional context on how neuromodulation fits within a broader therapeutic framework. For SPRAVATO® specifically, the concept of the neuroplasticity window has been discussed by researchers who propose that psychotherapy sessions delivered near the period of esketamine-associated synaptic plasticity may benefit from the altered cortical-limbic dynamics that occur during this period (Abdallah et al., 2018; Duman et al., 2019). Our clinical team at Complete Mind Care is attentive to this evidence and, where scheduling allows, works to coordinate therapy sessions in temporal proximity to SPRAVATO® treatment days. Results vary by individual, and the specific combination approach we recommend is individualized based on each patient’s clinical profile, history, and treatment preferences.
Psychotherapy Modalities We Integrate with Neuromodulation
At our Villanova clinic, we offer several psychotherapy modalities that are particularly well-suited for integration with TMS and SPRAVATO® treatment. Cognitive-behavioral therapy (CBT) is among the most studied psychotherapy approaches in relation to neuromodulation, and its structured, present-focused, skills-based nature makes it especially compatible with the neuroplastic state that neuromodulation may promote. CBT delivered during a TMS course helps patients actively practice cognitive restructuring and behavioral activation in a brain that may be more capable of encoding these skills.
Acceptance and Commitment Therapy (ACT), with its emphasis on psychological flexibility, values clarification, and defusion from ruminative thought patterns, is particularly relevant for patients whose depression or anxiety is characterized by pervasive experiential avoidance — a pattern that TMS and SPRAVATO® may reduce at the neurobiological level while ACT addresses the behavioral and experiential dimensions simultaneously. For patients presenting with trauma-related features alongside mood or anxiety disorders, trauma-focused approaches delivered alongside neuromodulation can address both the neurophysiological dysregulation and the narrative-cognitive dimensions of traumatic experience more comprehensively than either can alone.
Coordination at Complete Mind Care
One of the structural advantages we offer patients at our Villanova clinic is the ability to provide both neuromodulation and psychotherapy within a single, coordinated clinical setting. When TMS, SPRAVATO®, and therapy are delivered by providers who communicate regularly, share clinical observations, and collaboratively adjust the treatment plan, patients benefit from a more cohesive approach than fragmented care delivered across disconnected providers. Our clinical team includes board-certified psychiatrists, psychiatric nurse practitioners, licensed clinical social workers, and licensed professional counselors who hold regular case conferences and communicate actively across disciplines. Learn more about the professionals behind your care on our Meet Our Mental Health Team page.
For patients who have an existing therapy relationship outside our clinic, we are committed to collaborative care. We contact existing providers with patient consent, share treatment rationales and progress data, and work to ensure that our neuromodulation protocols are integrated intelligently into the patient’s ongoing therapeutic work rather than creating conflicting clinical messages. Discuss with your provider how your existing therapy relationship and our neuromodulation services can be coordinated for maximum benefit.
Practical Barriers and How We Address Them
One of the most common barriers we encounter among Main Line patients considering combined treatment is the logistical challenge of coordinating multiple therapeutic activities — particularly during an active TMS course that already requires daily clinic visits. We have designed our scheduling systems specifically to allow patients to complete a therapy session on the same clinic visit as their TMS treatment, reducing travel burden and helping patients maximize the neuroplasticity window that TMS creates.
A second barrier involves financial concerns about the cost of comprehensive combined treatment. Many patients have insurance coverage for both psychotherapy and neuromodulation but have not verified their combined benefit structure. Our administrative team works with patients to review their combined benefits, explore prior authorization pathways, and develop scheduling plans that make combined treatment financially and logistically achievable. We believe that access to the most effective evidence-based care — not just individual components of it — should be the standard for every patient we serve.
Building a Treatment Plan That Leads to Remission
Remission, not symptom management, is the explicit goal at Complete Mind Care. For the patients we see in Villanova and across the greater Philadelphia region — many of whom have lived with treatment-resistant conditions for years — the aspiration of remission may seem distant or even unrealistic. Our clinical philosophy is grounded in the conviction that this aspiration is achievable for a significantly larger proportion of patients than current treatment patterns produce, provided that the right combination of evidence-based interventions is deployed with clinical rigor, personalization, and genuine investment in the patient’s long-term outcome.
Combining psychotherapy with neuromodulation is not a luxury or an add-on. It is, based on the evidence, a clinically meaningful approach for many of the patients we treat. We bring more than a decade of TMS practice depth, built across 35 clinics and more than 4,500 patients, to every treatment plan we design — and we remain committed to integrating the latest evidence as the field evolves.
FAQ
Why is combining psychotherapy with neuromodulation more effective than either alone?
Neuromodulation techniques like TMS and SPRAVATO® may create a neuroplasticity window by modifying cortical activity and supporting synaptic remodeling. Psychotherapy works through learning-based neural change. When the two are delivered together, the brain’s enhanced plasticity state may support more effective encoding of the cognitive and behavioral changes that therapy aims to produce — a synergy supported by emerging clinical research in symptom reduction and functional improvement.
What type of therapy is best combined with TMS treatment?
Cognitive-behavioral therapy (CBT) is one of the most studied psychotherapy approaches in combination with TMS, and the evidence supporting their integration is developing. Acceptance and Commitment Therapy (ACT) and exposure-based therapies are also well-suited for integration with neuromodulation. The specific therapy approach we recommend depends on the patient’s presenting diagnosis, goals, and prior treatment history — our team tailors this recommendation during the initial evaluation.
Do I need to come more often if I am combining therapy and TMS?
Not necessarily. At Complete Mind Care, we design scheduling to allow therapy sessions to occur during the same clinic visit as TMS treatment, minimizing additional time commitment. Many patients complete therapy and TMS in a single scheduled block. We work with each patient to build a schedule that serves clinical goals without creating logistical barriers.
Is this approach covered by insurance?
Both TMS and psychotherapy services are covered by many major insurance plans when medically indicated, though the benefit structures are typically separate. SPRAVATO® has its own coverage pathway for eligible patients. Our team reviews all benefit components together at the initial consultation so that patients have a clear picture of their total coverage before treatment begins.
Can I start psychotherapy at Complete Mind Care if I am already receiving TMS or SPRAVATO® elsewhere?
Yes. We welcome patients who are receiving neuromodulation at other certified facilities and who wish to add or enhance their psychotherapy component. With appropriate consent, we communicate with your neuromodulation provider to coordinate timing and clinical approach. Conversely, if you are already in therapy elsewhere and wish to add neuromodulation at our Villanova clinic, we will coordinate with your existing therapist.
Key Takeaways
- Neuromodulation, including TMS and SPRAVATO®, may create a neuroplasticity window that supports the brain’s capacity for the learning-based changes that psychotherapy aims to produce.
- Clinical research supports the rationale for combining psychotherapy and neuromodulation, while optimal timing and sequencing protocols continue to evolve.
- Complete Mind Care offers coordinated psychotherapy and neuromodulation within a single integrated clinic, with scheduling designed to minimize patient time burden.
- CBT and acceptance-based therapies are well-suited psychotherapy modalities for combination with TMS and SPRAVATO®.
- Our clinical team actively coordinates with outside providers for patients who are receiving components of their care elsewhere.
Medical Disclaimer: The information provided in this blog is for educational purposes only and does not constitute medical advice. Treatment outcomes vary by individual. Results may vary. Please consult with a qualified healthcare provider before beginning any new treatment. Discuss with your provider whether this treatment is appropriate for you.
Conclusion
The evidence is clear: for patients with depression, anxiety, and related conditions, combining psychotherapy with neuromodulation can support outcomes that may exceed either approach in isolation. At Complete Mind Care in Villanova, this integration is not incidental — it is central to our clinical design and reflects our commitment to evidence-based, remission-focused care for every patient we serve on the Main Line and throughout the greater Philadelphia area. If you are ready to explore a comprehensive treatment approach that harnesses both the neurobiological power of neuromodulation and the enduring learning potential of psychotherapy, we invite you to schedule a consultation. Our Villanova clinic is located at 795 E Lancaster Ave, Suite 210, Villanova, PA 19085. Call us at 215-918-7939. Remission is our mission.
References
Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2018). The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation? Pharmacology & Therapeutics, 190, 148–158. https://doi.org/10.1016/j.pharmthera.2018.05.010
Bajbouj, M., & Padberg, F. (2014). A perfect match: Noninvasive brain stimulation and psychotherapy. European Archives of Psychiatry and Clinical Neuroscience, 264(Suppl. 1), S27–S33. https://doi.org/10.1007/s00406-014-0540-6
Donse, L., Padberg, F., Sack, A. T., Rush, A. J., & Arns, M. (2018). Simultaneous rTMS and psychotherapy in major depressive disorder: Clinical outcomes and predictors from a large naturalistic study. Brain Stimulation, 11(2), 337–345. https://doi.org/10.1016/j.brs.2017.11.004
Duman, R. S., Sanacora, G., & Krystal, J. H. (2019). Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron, 102(1), 75–90. https://doi.org/10.1016/j.neuron.2019.03.013
Isserles, M., Rosenberg, O., Dannon, P., Levkovitz, Y., Kotler, M., Deutsch, F., Lerer, B., & Zangen, A. (2011). Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome. Journal of Affective Disorders, 128(3), 235–242. https://doi.org/10.1016/j.jad.2010.06.038
Kochanowski, B., Hunter, A. M., & Leuchter, A. F. (2024). A review of transcranial magnetic stimulation and mindfulness-based therapies in major depressive disorder. Journal of Affective Disorders, 353, 652–662. https://doi.org/10.1016/j.jad.2024.03.068